Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.

Identifieur interne : 000025 ( PubMed/Checkpoint ); précédent : 000024; suivant : 000026

Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.

Auteurs : Jing Li [République populaire de Chine] ; Sen Zhang [République populaire de Chine] ; Bo Li [République populaire de Chine] ; Yi Hu [République populaire de Chine] ; Xiao-Ping Kang [République populaire de Chine] ; Xiao-Yan Wu [République populaire de Chine] ; Meng-Ting Huang [République populaire de Chine] ; Yu-Chang Li [République populaire de Chine] ; Zhong-Peng Zhao [République populaire de Chine] ; Cheng-Feng Qin [République populaire de Chine] ; Tao Jiang [République populaire de Chine]

Source :

RBID : pubmed:31750915

Abstract

Each influenza pandemic was caused at least partly by avian- and/or swine-origin influenza A viruses (IAVs). The timing of and the potential IAVs involved in the next pandemic are currently unpredictable. We aim to build machine learning (ML) models to predict human-adaptive IAV nucleotide composition. A total of 217,549 IAV full-length coding sequences of the PB2 (polymerase basic protein-2), PB1, PA (polymerase acidic protein), HA (hemagglutinin), NP (nucleoprotein), and NA (neuraminidase) segments were decomposed for their codon position-based mononucleotides (12 nts) and dinucleotides (48 dnts). A total of 68,742 human sequences and 68,739 avian sequences (1:1) were resampled to characterize the human adaptation-associated (d)nts with principal component analysis (PCA) and other ML models. Then, the human adaptation of IAV sequences was predicted based on the characterized (d)nts. Respectively, 9, 12, 11, 13, 10 and 9 human-adaptive (d)nts were optimized for the six segments. PCA and hierarchical clustering analysis revealed the linear separability of the optimized (d)nts between the human-adaptive and avian-adaptive sets. The results of the confusion matrix and the area under the receiver operating characteristic curve indicated a high performance of the ML models to predict human adaptation of IAVs. Our model performed well in predicting the human adaptation of the swine/avian IAVs before and after the 2009 H1N1 pandemic. In conclusion, we identified the human adaptation-associated genomic composition of IAV segments. ML models for IAV human adaptation prediction using large IAV genomic data sets can facilitate the identification of key viral factors that affect virus transmission/pathogenicity. Most importantly, it allows the prediction of pandemic influenza.

DOI: 10.1093/molbev/msz276
PubMed: 31750915


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31750915

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.</title>
<author>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Sen" sort="Zhang, Sen" uniqKey="Zhang S" first="Sen" last="Zhang">Sen Zhang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Bo" sort="Li, Bo" uniqKey="Li B" first="Bo" last="Li">Bo Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Laboratory, the Fifth Medical Centre of Chinese PLA General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Clinical Laboratory, the Fifth Medical Centre of Chinese PLA General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hu, Yi" sort="Hu, Yi" uniqKey="Hu Y" first="Yi" last="Hu">Yi Hu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kang, Xiao Ping" sort="Kang, Xiao Ping" uniqKey="Kang X" first="Xiao-Ping" last="Kang">Xiao-Ping Kang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Xiao Yan" sort="Wu, Xiao Yan" uniqKey="Wu X" first="Xiao-Yan" last="Wu">Xiao-Yan Wu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Huang, Meng Ting" sort="Huang, Meng Ting" uniqKey="Huang M" first="Meng-Ting" last="Huang">Meng-Ting Huang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Yu Chang" sort="Li, Yu Chang" uniqKey="Li Y" first="Yu-Chang" last="Li">Yu-Chang Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Zhong Peng" sort="Zhao, Zhong Peng" uniqKey="Zhao Z" first="Zhong-Peng" last="Zhao">Zhong-Peng Zhao</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infection and Immunology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Infection and Immunology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qin, Cheng Feng" sort="Qin, Cheng Feng" uniqKey="Qin C" first="Cheng-Feng" last="Qin">Cheng-Feng Qin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Tao" sort="Jiang, Tao" uniqKey="Jiang T" first="Tao" last="Jiang">Tao Jiang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31750915</idno>
<idno type="pmid">31750915</idno>
<idno type="doi">10.1093/molbev/msz276</idno>
<idno type="wicri:Area/PubMed/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000074</idno>
<idno type="wicri:Area/PubMed/Curation">000074</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000074</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000025</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000025</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.</title>
<author>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Sen" sort="Zhang, Sen" uniqKey="Zhang S" first="Sen" last="Zhang">Sen Zhang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Bo" sort="Li, Bo" uniqKey="Li B" first="Bo" last="Li">Bo Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Laboratory, the Fifth Medical Centre of Chinese PLA General Hospital, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Clinical Laboratory, the Fifth Medical Centre of Chinese PLA General Hospital, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hu, Yi" sort="Hu, Yi" uniqKey="Hu Y" first="Yi" last="Hu">Yi Hu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kang, Xiao Ping" sort="Kang, Xiao Ping" uniqKey="Kang X" first="Xiao-Ping" last="Kang">Xiao-Ping Kang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Xiao Yan" sort="Wu, Xiao Yan" uniqKey="Wu X" first="Xiao-Yan" last="Wu">Xiao-Yan Wu</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Huang, Meng Ting" sort="Huang, Meng Ting" uniqKey="Huang M" first="Meng-Ting" last="Huang">Meng-Ting Huang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Li, Yu Chang" sort="Li, Yu Chang" uniqKey="Li Y" first="Yu-Chang" last="Li">Yu-Chang Li</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Zhong Peng" sort="Zhao, Zhong Peng" uniqKey="Zhao Z" first="Zhong-Peng" last="Zhao">Zhong-Peng Zhao</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Infection and Immunology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Infection and Immunology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Qin, Cheng Feng" sort="Qin, Cheng Feng" uniqKey="Qin C" first="Cheng-Feng" last="Qin">Cheng-Feng Qin</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Tao" sort="Jiang, Tao" uniqKey="Jiang T" first="Tao" last="Jiang">Tao Jiang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing</wicri:regionArea>
<placeName>
<settlement type="city">Pékin</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Molecular biology and evolution</title>
<idno type="eISSN">1537-1719</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Each influenza pandemic was caused at least partly by avian- and/or swine-origin influenza A viruses (IAVs). The timing of and the potential IAVs involved in the next pandemic are currently unpredictable. We aim to build machine learning (ML) models to predict human-adaptive IAV nucleotide composition. A total of 217,549 IAV full-length coding sequences of the PB2 (polymerase basic protein-2), PB1, PA (polymerase acidic protein), HA (hemagglutinin), NP (nucleoprotein), and NA (neuraminidase) segments were decomposed for their codon position-based mononucleotides (12 nts) and dinucleotides (48 dnts). A total of 68,742 human sequences and 68,739 avian sequences (1:1) were resampled to characterize the human adaptation-associated (d)nts with principal component analysis (PCA) and other ML models. Then, the human adaptation of IAV sequences was predicted based on the characterized (d)nts. Respectively, 9, 12, 11, 13, 10 and 9 human-adaptive (d)nts were optimized for the six segments. PCA and hierarchical clustering analysis revealed the linear separability of the optimized (d)nts between the human-adaptive and avian-adaptive sets. The results of the confusion matrix and the area under the receiver operating characteristic curve indicated a high performance of the ML models to predict human adaptation of IAVs. Our model performed well in predicting the human adaptation of the swine/avian IAVs before and after the 2009 H1N1 pandemic. In conclusion, we identified the human adaptation-associated genomic composition of IAV segments. ML models for IAV human adaptation prediction using large IAV genomic data sets can facilitate the identification of key viral factors that affect virus transmission/pathogenicity. Most importantly, it allows the prediction of pandemic influenza.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Data-Review" Owner="NLM">
<PMID Version="1">31750915</PMID>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1537-1719</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>37</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2020</Year>
<Month>Apr</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Molecular biology and evolution</Title>
<ISOAbbreviation>Mol. Biol. Evol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.</ArticleTitle>
<Pagination>
<MedlinePgn>1224-1236</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/molbev/msz276</ELocationID>
<Abstract>
<AbstractText>Each influenza pandemic was caused at least partly by avian- and/or swine-origin influenza A viruses (IAVs). The timing of and the potential IAVs involved in the next pandemic are currently unpredictable. We aim to build machine learning (ML) models to predict human-adaptive IAV nucleotide composition. A total of 217,549 IAV full-length coding sequences of the PB2 (polymerase basic protein-2), PB1, PA (polymerase acidic protein), HA (hemagglutinin), NP (nucleoprotein), and NA (neuraminidase) segments were decomposed for their codon position-based mononucleotides (12 nts) and dinucleotides (48 dnts). A total of 68,742 human sequences and 68,739 avian sequences (1:1) were resampled to characterize the human adaptation-associated (d)nts with principal component analysis (PCA) and other ML models. Then, the human adaptation of IAV sequences was predicted based on the characterized (d)nts. Respectively, 9, 12, 11, 13, 10 and 9 human-adaptive (d)nts were optimized for the six segments. PCA and hierarchical clustering analysis revealed the linear separability of the optimized (d)nts between the human-adaptive and avian-adaptive sets. The results of the confusion matrix and the area under the receiver operating characteristic curve indicated a high performance of the ML models to predict human adaptation of IAVs. Our model performed well in predicting the human adaptation of the swine/avian IAVs before and after the 2009 H1N1 pandemic. In conclusion, we identified the human adaptation-associated genomic composition of IAV segments. ML models for IAV human adaptation prediction using large IAV genomic data sets can facilitate the identification of key viral factors that affect virus transmission/pathogenicity. Most importantly, it allows the prediction of pandemic influenza.</AbstractText>
<CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhang</LastName>
<ForeName>Sen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Bo</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Laboratory, the Fifth Medical Centre of Chinese PLA General Hospital, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hu</LastName>
<ForeName>Yi</ForeName>
<Initials>Y</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kang</LastName>
<ForeName>Xiao-Ping</ForeName>
<Initials>XP</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Xiao-Yan</ForeName>
<Initials>XY</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Meng-Ting</ForeName>
<Initials>MT</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Graduate School, Anhui Medical University, Hefei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Li</LastName>
<ForeName>Yu-Chang</ForeName>
<Initials>YC</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zhao</LastName>
<ForeName>Zhong-Peng</ForeName>
<Initials>ZP</Initials>
<AffiliationInfo>
<Affiliation>Department of Infection and Immunology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Qin</LastName>
<ForeName>Cheng-Feng</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jiang</LastName>
<ForeName>Tao</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Graduate School, Anhui Medical University, Hefei, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mol Biol Evol</MedlineTA>
<NlmUniqueID>8501455</NlmUniqueID>
<ISSNLinking>0737-4038</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">dinucleotide</Keyword>
<Keyword MajorTopicYN="N">genomic nucleotide composition</Keyword>
<Keyword MajorTopicYN="N">human adaptation</Keyword>
<Keyword MajorTopicYN="N">influenza A viruses (IAVs)</Keyword>
<Keyword MajorTopicYN="N">machine learning (ML)</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>11</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31750915</ArticleId>
<ArticleId IdType="pii">5637231</ArticleId>
<ArticleId IdType="doi">10.1093/molbev/msz276</ArticleId>
<ArticleId IdType="pmc">PMC7086167</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Molecules. 2018 Jun 29;23(7):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29966263</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10227-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9294192</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2018 Nov 2;362(6414):577-580</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30385576</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Feb 25;11(2):e0150173</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26915079</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Med. 2000;51:407-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10774473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Mar 18;350(12):1179-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2014;385:359-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24990620</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>US Army Med Dep J. 2013 Jan-Mar;:45-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23277445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Evol. 1993 May;10(3):512-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8336541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Evol. 2016 Jul;33(7):1870-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27004904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S1-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21342879</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Virol. 2015 Aug;13:101-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26126082</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 1981;59(1):75-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6973418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Jun 25;459(7250):1122-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19516283</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2017 Nov 13;65(11):1927-1929</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29020187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2000 Nov;57(12):1770-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11130181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2007;35(20):6798-807</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17932072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2011 Jan;5(1):13-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21138536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 May 26;473(7348):519-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21614079</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Apr 3;370(14):1335-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24693893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2014 Apr;42(7):4527-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24470146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2006 Apr 7;125(1):173-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16615898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2013 Aug 21;13:386</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23964903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 May 25;18(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28587080</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2017 Oct 5;550(7674):124-127</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28953888</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2019 Jan;17(2):67-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30487536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2007 Sep;13(9):1348-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18252106</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2018 Apr;23(15):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29667576</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2018 May 14;92(11):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29540597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2009 Mar 31;53(13):1130-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19324258</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2010 Jun 25;7(6):440-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20542248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2017 Mar 30;22(13):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28382917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2006 Oct;12(10):1203-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16964257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26953178</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D466-D474</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27679478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2014 Jun 26;19(25):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24993556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):12121-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16880383</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Nov 09;6:36839</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27827462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Oct 10;502(7470):241-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23965623</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Elife. 2014 Dec 09;3:e04531</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25490153</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Biotechnol. 2006 Dec;24(12):1565-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17160063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IEEE Trans Pattern Anal Mach Intell. 1982 Feb;4(2):99-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21869012</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2016 Apr 22;60(5):2981-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26953209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci China Life Sci. 2017 Dec;60(12):1331-1339</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29019145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2004 Nov;2(11):909-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15494747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosystems. 2017 Jan;151:21-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27887904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2015 Mar 27;6:6696</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25813399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2013 Aug 06;347:f4730</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23920349</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2018 Oct 29;92(22):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30158292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1978 Feb;84(2):268-78</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2017 Mar 29;91(8):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28148785</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
<settlement>
<li>Pékin</li>
</settlement>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Li, Jing" sort="Li, Jing" uniqKey="Li J" first="Jing" last="Li">Jing Li</name>
</noRegion>
<name sortKey="Hu, Yi" sort="Hu, Yi" uniqKey="Hu Y" first="Yi" last="Hu">Yi Hu</name>
<name sortKey="Huang, Meng Ting" sort="Huang, Meng Ting" uniqKey="Huang M" first="Meng-Ting" last="Huang">Meng-Ting Huang</name>
<name sortKey="Jiang, Tao" sort="Jiang, Tao" uniqKey="Jiang T" first="Tao" last="Jiang">Tao Jiang</name>
<name sortKey="Kang, Xiao Ping" sort="Kang, Xiao Ping" uniqKey="Kang X" first="Xiao-Ping" last="Kang">Xiao-Ping Kang</name>
<name sortKey="Li, Bo" sort="Li, Bo" uniqKey="Li B" first="Bo" last="Li">Bo Li</name>
<name sortKey="Li, Yu Chang" sort="Li, Yu Chang" uniqKey="Li Y" first="Yu-Chang" last="Li">Yu-Chang Li</name>
<name sortKey="Qin, Cheng Feng" sort="Qin, Cheng Feng" uniqKey="Qin C" first="Cheng-Feng" last="Qin">Cheng-Feng Qin</name>
<name sortKey="Wu, Xiao Yan" sort="Wu, Xiao Yan" uniqKey="Wu X" first="Xiao-Yan" last="Wu">Xiao-Yan Wu</name>
<name sortKey="Zhang, Sen" sort="Zhang, Sen" uniqKey="Zhang S" first="Sen" last="Zhang">Sen Zhang</name>
<name sortKey="Zhao, Zhong Peng" sort="Zhao, Zhong Peng" uniqKey="Zhao Z" first="Zhong-Peng" last="Zhao">Zhong-Peng Zhao</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000025 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000025 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:31750915
   |texte=   Machine Learning Methods for Predicting Human-Adaptive Influenza A Viruses Based on Viral Nucleotide Compositions.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:31750915" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021